correctionAn earlier version of this article misstated that the $1.6 billion settlement with U.S. women and Bayer resulted from a class-action lawsuit. It has been corrected to identify that it ...

Bayer will pay $1.6 billion to settle lawsuits from thousands of American women who said they developed debilitating long-term health problems from the pharmaceutical giant’s product, the Essure birth ...

Two years after Bayer threw in the towel and agreed to stop selling its controversial Essure birth control implant in the United States, the company might finally be able to put the issue in the ...

Bayer AGBAYN2.82%increase; green up pointing triangle said Thursday it will pay $1.6 billion to settle claims that its birth control device Essure causes serious health complications, the latest in a ...

LEVERKUSEN, Germany--(BUSINESS WIRE)--Bayer announced today that it has reached agreements with plaintiff law firms to resolve approximately 90% of the nearly 39,000 total filed and unfiled U.S.

A Bayer AG official warned the company of increased government scrutiny of injuries from its Essure contraceptive implant years before it was pulled from the market, according to recently unsealed ...

FDA recently updated its Essure website to include an analysis of medical device reports received in 2018. The agency said it received about 6,000 medical device reports in 2018 related to the Essure ...

The FDA and Bayer are revising and extending a postmarket safety study of the Essure permanent birth control implant, following earlier regulatory actions restricting its use and the company’s ...

Since 2002, Essure has been marketed as a permanent birth control method for women that is convenient and can be performed in their own doctor’s office. The procedure is simple: A 4-centimeter metal ...

WHIPPANY, N.J., July 26, 2018 /PRNewswire/ -- Bayer is reminding women with Essure that the safety profile of Essure, the only Food and Drug Administration (FDA)-approved non-incisional form of ...

When Christina Potts was looking for permanent birth control, she said, her doctor was a “cheerleader” for one option and one option only: Essure. Potts says the device, which is implanted in a ...

The pharma company said the decision was based on poor sales, not health risks. Editor's Note: After the July 26, 2018 "Good Morning America" broadcast report, Bayer provided us with a statement which ...